2004Chinese Journal of Hospital PharmacyRequires access

Effect of Shengmai injection on mice's liver drug metabolizing enzyme

Ke Li

Open publisher page 0 citations

Abstract

OBJECTIVE To investigate the effect of Shengmai injection (SMI) on the drug metabolizing enzyme of liver in mice.METHODS Mice were given SMI( 7.5, 1 5mL·kg -1,ip), half an hour later, hypnotic effects of pentobarbital sodium or barbital sodium were observed. After given with SMI for six days, the hypnotic effect of pentobarbital sodium, liver index and the total contents of microsomal cytochrome P450(CYP) were examined at the last administration 24h later.RESULTS When given only once, SMI at higher dose prolonged markedly hypnotic duration of pentobarbital sodium (P 0.01), and yet it hardly influenced the hypnotic effect of barbital sodium. When given for six days, the reduction of hypnotic duration of pentobarbital sodium, and the increases of liver index and total content of liver CYP were found in two SMI groups (P 0.05, P 0.01).CONCLUSION SMI could inhibit or induce drug metabolizing enzyme of liver, which would be related to the period of administration and the time of experimental observation.

About this research paper

What this paper is about

OBJECTIVE To investigate the effect of Shengmai injection (SMI) on the drug metabolizing enzyme of liver in mice.METHODS Mice were given SMI( 7.5, 1 5mL·kg -1,ip), half an hour later, hypnotic effects of pentobarbital sodium or barbital sodium were observed. After given with SMI for six days, the hypnotic effect of pentobarbital sodium, liver index and the total contents of microsomal cytochrome P450(CYP) were examined at the last administration 24h later.RESULTS When given only once, SMI at higher dose prolonged markedly hypnotic duration of pentobarbital sodium (P 0.01), and yet it hardly influenced the hypnotic effect of barbital sodium. When given for six days, the reduction of hypnotic duration of pentobarbital sodium, and the increases of liver index and total content of liver CYP were found in two SMI groups (P 0.05, P 0.01).CONCLUSION SMI could inhibit or induce drug metabolizing enzyme of liver, which would be related to the period of administration and the time of experimental observation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To investigate the effect of Shengmai injection (SMI) on the drug metabolizing enzyme of liver in mice.METHODS Mice were given SMI( 7.5, 1 5mL·kg -1,ip), half an hour later, hypnotic effects of pentobarbital sodium or barbital sodium were observed. After given with SMI for six days, the hypnotic effect of pentobarbital sodium, liver index and the total contents of microsomal cytochrome P450(CYP) were examined at the last administration 24h later.RESULTS When given only once, SMI at higher dose prolonged markedly hypnotic duration of pentobarbital sodium (P 0.01), and yet it hardly influenced the hypnotic effect of barbital sodium. When given for six days, the reduction of hypnotic duration of pentobarbital sodium, and the increases of liver index and total content of liver CYP were found in two SMI groups (P 0.05, P 0.01).CONCLUSION SMI could inhibit or induce drug metabolizing enzyme of liver, which would be related to the period of administration and the time of experimental observation.

Key concepts: Pentobarbital, Barbital, Hypnotic, Pharmacology, Chemistry, Sodium, Liver enzyme, Drug

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of Shengmai injection on mice's liver drug metabolizing enzyme — Research Paper | ScholarLens